Tuoxin Pharmaceutical Group (301089.SZ) is planning to invest 10 million yuan to acquire a stake in Jinshi Biotechnology.

Tuoxin Pharmaceutical Group (301089.SZ) announced that the company will increase its investment in Jiangsu Ensan Biotechnology Co., Ltd. ("Ensan Biotech") with its own funds of 10 million yuan, of which 223,377 yuan will be included in the registered capital and the remaining part will be included in the capital surplus. The company has signed an agreement on the investment in Jiangsu Ensan Biotechnology Co., Ltd. After this transaction is completed, the company will directly hold 1.75% of the shares of Ensan Biotech. Ensan Biotech is a synthetic biotechnology company that integrates research and development, production, and sales, focusing on the research and development, production, and industrial application of podophyllotoxin. Ensan Biotech has successfully achieved the preparation of high-purity podophyllotoxin through breakthroughs in strain construction, fermentation, purification, and industrialized mass production. Its main products include podophyllotoxin skincare products, oral capsules, eye drops, etc. Given the company's technical advantages in process development in the fields of chemistry and synthetic biology, the target company has upstream and downstream sales advantages. Currently, the company is actively deploying in the field of health products, successfully reserving core preparation technologies for products such as podophyllotoxin. In the future, as the business volume of the target company gradually increases, if the original production capacity or output of the target company is insufficient to meet market demand, the company is expected to better play a role in supplementing production capacity in the future to achieve efficient business alignment. This external investment is an important measure for the company to extend its production, sales, and research and development industry chain, which is beneficial for future industrial horizontal expansion, enhancing market competitiveness and sustainable profitability, and has a positive significance for improving and strengthening the company's production, sales, and research and development layout.